Cargando…

Kawasaki Disease and Peripheral Gangrene in Infancy

INTRODUCTION: Early diagnosis and treatment of Kawasaki disease as the most common cause of acquired heart disease in childhood, may significantly improve the prognosis. Diagnosing infantile Kawasaki (younger than a year) is difficult because of obscure symptoms; at the same time they are at the hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Malekzadeh, Iran, Ziaee, Vahid, Sadrosadat, Taravat, Moardinejad, Mohammad-Hassan, Sayadpour-Zanjani, Keyhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662841/
https://www.ncbi.nlm.nih.gov/pubmed/26635941
http://dx.doi.org/10.5812/ijp.3309
_version_ 1782403217360945152
author Malekzadeh, Iran
Ziaee, Vahid
Sadrosadat, Taravat
Moardinejad, Mohammad-Hassan
Sayadpour-Zanjani, Keyhan
author_facet Malekzadeh, Iran
Ziaee, Vahid
Sadrosadat, Taravat
Moardinejad, Mohammad-Hassan
Sayadpour-Zanjani, Keyhan
author_sort Malekzadeh, Iran
collection PubMed
description INTRODUCTION: Early diagnosis and treatment of Kawasaki disease as the most common cause of acquired heart disease in childhood, may significantly improve the prognosis. Diagnosing infantile Kawasaki (younger than a year) is difficult because of obscure symptoms; at the same time they are at the higher risk of coronary abnormalities. CASE PRESENTATION: We report three infants with prolonged (more than 5 days) fever and peripheral gangrene without any other clinical manifestations of Kawasaki disease. Kawasaki was diagnosed due to dilation of coronary artery and other aortic branches, thrombocytosis, and rising of ESR and CRP. All patients were treated with high dose aspirin, IVIG and pulse therapy with methylprednisolone. Additionally, cytotoxic drugs or infliximab were used for two of them because of severe aneurysms in the aortic branches. All 3 patients received aspirin with anti-platelet aggregation dose and 2 patients heparin as an anti-coagulant agent for longtime. After adequate treatment, peripheral gangrene, arterial dilations and aneurysms improved, but during 12 months follow-up coronary aneurysms did not improve completely. CONCLUSIONS: Peripheral gangrene must be regarded as an important sign of infantile Kawasaki disease early treatment of which can prevent severe permanent coronary involvements and sequels.
format Online
Article
Text
id pubmed-4662841
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Kowsar
record_format MEDLINE/PubMed
spelling pubmed-46628412015-12-03 Kawasaki Disease and Peripheral Gangrene in Infancy Malekzadeh, Iran Ziaee, Vahid Sadrosadat, Taravat Moardinejad, Mohammad-Hassan Sayadpour-Zanjani, Keyhan Iran J Pediatr Case Report INTRODUCTION: Early diagnosis and treatment of Kawasaki disease as the most common cause of acquired heart disease in childhood, may significantly improve the prognosis. Diagnosing infantile Kawasaki (younger than a year) is difficult because of obscure symptoms; at the same time they are at the higher risk of coronary abnormalities. CASE PRESENTATION: We report three infants with prolonged (more than 5 days) fever and peripheral gangrene without any other clinical manifestations of Kawasaki disease. Kawasaki was diagnosed due to dilation of coronary artery and other aortic branches, thrombocytosis, and rising of ESR and CRP. All patients were treated with high dose aspirin, IVIG and pulse therapy with methylprednisolone. Additionally, cytotoxic drugs or infliximab were used for two of them because of severe aneurysms in the aortic branches. All 3 patients received aspirin with anti-platelet aggregation dose and 2 patients heparin as an anti-coagulant agent for longtime. After adequate treatment, peripheral gangrene, arterial dilations and aneurysms improved, but during 12 months follow-up coronary aneurysms did not improve completely. CONCLUSIONS: Peripheral gangrene must be regarded as an important sign of infantile Kawasaki disease early treatment of which can prevent severe permanent coronary involvements and sequels. Kowsar 2015-12-23 2015-12 /pmc/articles/PMC4662841/ /pubmed/26635941 http://dx.doi.org/10.5812/ijp.3309 Text en Copyright © 2015, Growth & Development Research Center. http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Case Report
Malekzadeh, Iran
Ziaee, Vahid
Sadrosadat, Taravat
Moardinejad, Mohammad-Hassan
Sayadpour-Zanjani, Keyhan
Kawasaki Disease and Peripheral Gangrene in Infancy
title Kawasaki Disease and Peripheral Gangrene in Infancy
title_full Kawasaki Disease and Peripheral Gangrene in Infancy
title_fullStr Kawasaki Disease and Peripheral Gangrene in Infancy
title_full_unstemmed Kawasaki Disease and Peripheral Gangrene in Infancy
title_short Kawasaki Disease and Peripheral Gangrene in Infancy
title_sort kawasaki disease and peripheral gangrene in infancy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662841/
https://www.ncbi.nlm.nih.gov/pubmed/26635941
http://dx.doi.org/10.5812/ijp.3309
work_keys_str_mv AT malekzadehiran kawasakidiseaseandperipheralgangreneininfancy
AT ziaeevahid kawasakidiseaseandperipheralgangreneininfancy
AT sadrosadattaravat kawasakidiseaseandperipheralgangreneininfancy
AT moardinejadmohammadhassan kawasakidiseaseandperipheralgangreneininfancy
AT sayadpourzanjanikeyhan kawasakidiseaseandperipheralgangreneininfancy